Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. (Move&FG)
Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. "Effets de l'entraînement Physique Intensif Sur la plasticité cérébrale, la Cognition et le Bien être Psychologique".
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Anne G De Volder, MD, PhD
- Phone Number: +32 2 764 54 82
- Email: anne.de.volder@uclouvain.be
Study Contact Backup
- Name: Yannick Bleyenheuft, PhD
- Email: yannick.bleyenheuft@uclouvain.be
Study Locations
-
-
-
Brussels, Belgium, 1200
- Recruiting
- Université Catholique de Louvain
-
Contact:
- Anne G De Volder, MD, PhD
- Phone Number: +32 2 764 5482
- Email: anne.de.volder@uclouvain.be
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- involved in education program
- absence of contra-indication of physical activity
- does accept randomization
- no history of neurological illness or brain trauma
- no history of psychiatric illness (exclusion of psychotic symptoms)
- absence of contra-indication to magnetic resonance imaging
- no uncorrected sensory impairment (must understand the therapist)
- absence of conduct disorders (violence, school bullying)
Exclusion Criteria:
- does not provide informed consent
- unstable diabetes
- Body mass index above P95 (or above 30 for adults) (except medical authorization)
- coagulation disorders
- severe and unstable asthma
- history of hearth malformation or heart disease
- medical conditions prohibiting sport or contraindicating physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise
The experimental, intensive exercise regime will include 50-min sessions four times a week during five weeks (for a total of about 17 hours) combining structured aerobic exercise (at least 20 minutes jogging and moderate to high intensity active games) and anaerobic lactic resistance exercise (power training with gymn weights).
|
Moderate to high intensity physical training
Other Names:
|
|
Active Comparator: Relaxation
The control activity will include 50-min sessions four times a week during five weeks (for a total of about 17 hours) combining mindfulness, stretching and low intensity active games (breath control, proprioception, walking, social relaxation, flexibility training).
|
Low intensity physical activity and relaxation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline psychological well-being as assessed using depression and anxiety questionnaires
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Hospital Anxiety Depression Scale (HADS) in french version for all participants, mainly suitable for inpatients
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline psychological well-being as assessed using self-esteem, mood and anxiety questionnaires
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
State-Trait Anxiety Inventory (STAI) in french version for all participants, mainly suitable for outpatients
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline psychological well-being as assessed using depression questionnaires for children
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Children's Depression Inventory (CDI) in french version
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline psychological well-being as assessed using depression questionnaires for adolescents and adults
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Beck Depression Inventory (BDI-13) in french version
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline psychological well-being as assessed using depression questionnaire for young people and adults
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Self-depression scale (SDS) in french version
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline psychological well-being as assessed using self-esteem questionnaires
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Self-perception profile for children or adolescents in french version
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline physical condition : size
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Height in meters
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline physical condition : weight
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Weight in kilograms
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline physical condition as assessed in bioelectrical impedance analysis
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Body mass index (BMI) in kilograms divided by the square of the height in meters (kg/m2)
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline physical condition : body muscle ratio
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Body muscle percentage : {body muscle mass (kg) / total body mass (kg)} x 100
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline physical condition : body fat ratio
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Body fat percentage : {body fat mass (kg) / total body mass (kg)} x 100
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline physical condition as assessed using field running tests or a cycle ergometer
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
An estimation of maximal oxygen consumption in field running test (20m-beep test). A submaximal effort test using a cycle ergometer. |
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline cognitive function as assessed using computerized neuropsychological testing of cognitive control
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Attention and conflict resolution testing using a variant of the Eriksen Flanker task, adapted for age, in E-Prime.
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
|
Change from baseline cognitive function as assessed using computerized neuropsychological testing of inhibitory control
Time Frame: at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Inhibitory control testing using a go-no go test adapted in E-Prime.
|
at 3 weeks, at 6 weeks and through study completion, up to 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Anne G De Volder, MD, PhD, Université Catholique de Louvain
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Etude 2016/17FEV/060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.